Mark R Jones Net Worth

The estimated Net Worth of Mark R Jones is at least $4.43 millió dollars as of 3 November 2021. Mark Jones owns over 750 units of Cencora stock worth over $2,628,184 and over the last 7 years Mark sold COR stock worth over $1,804,351.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mark Jones COR stock SEC Form 4 insiders trading

Mark has made over 24 trades of the Cencora stock since 2018, according to the Form 4 filled with the SEC. Most recently Mark sold 750 units of COR stock worth $110,993 on 3 November 2021.

The largest trade Mark's ever made was selling 1,082 units of Cencora stock on 15 March 2021 worth over $126,940. On average, Mark trades about 603 units every 49 days since 2018. As of 3 November 2021 Mark still owns at least 11,126 units of Cencora stock.

You can see the complete history of Mark Jones stock trades at the bottom of the page.

What's Mark Jones's mailing address?

Mark's mailing address filed with the SEC is C/O CORESITE REALTY CORPORATION, 1001 17TH STREET, SUITE 500, DENVER, CO, 80202.

Insiders trading at Cencora

Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... és Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.

What does Cencora do?

amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.

Complete history of Mark Jones stock trades at Cencora

Cencora executives and stock owners

Cencora executives and other stock owners filed with the SEC include:

• Paul Szurek,
  President, Chief Executive Officer, Director
• Steven Smith,
  Chief Revenue Officer
• Jeffrey Finnin,
  Chief Financial Officer
• Derek McCandless,
  Senior Vice President - Legal, General Counsel, Secretary
• Brian Warren,
  Senior Vice President - Development and Product Engineering
• David Wilson,
  Lead Independent Director
• John Thompson,
  Independent Director
• Michael Koehler,
  Independent Director
• Jean Bua,
  Independent Director
• Kelly Chambliss,
  Independent Director
• Patricia Higgins,
  Independent Director
• James Attwood,
  Independent Director
• Juan Font,
  Senior Vice President - General Management
• Maile Kaiser,
  Senior Vice President of Sales
• Robert Stuckey,
  Independent Chairman of the Board
• Thomas M. Ray,
  President and CEO
• Dominic M. Tobin,
  SVP, Operations
• Realty Iii, Gp, L.L.C.Carly...,
  
• Iv Aiv Gp, L.L.C.Crp Iv Aiv...,
  
• Group Management L.L.C.Carl...,
  
• Anthony Hatzenbuehler,
  SVP, Field Operations
• Mark R Jones,
  Chief Accounting Officer
• Group Management L.L.C.Carl...,
  
• Robert K. Rockwood,
  SVP, Acquisitions
• Jarrett Appleby,
  Chief Operating Officer
• Christopher K Ancell,
  SVP, Sales
• Billie R. Haggard,
  SVP, Data Centers
• Christopher M. Bair,
  SVP, Sales
• David W. Dunn,
  SVP, Strategy and Marketing
• Chuck D. Price,
  SVP, Information Technology
• Robert M. Sistek,
  SVP, Capital Markets
• Deedee M. Beckman,
  Chief Financial Officer
• Realty V Gp, L.L.C.Carlyle ...,
  
• Iv Aiv Gp, L.L.C.Crp Iv Aiv...,
  
• Michael Millegan,
  Director
• Aleksandra Krusko,
  SVP, IT and Digitization